![Resistencias al tratamiento no quirúrgico en cáncer cutáneo no melanoma. Parte I: tratamientos tópicos - ScienceDirect Resistencias al tratamiento no quirúrgico en cáncer cutáneo no melanoma. Parte I: tratamientos tópicos - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000173101630151X-gr3.jpg)
Resistencias al tratamiento no quirúrgico en cáncer cutáneo no melanoma. Parte I: tratamientos tópicos - ScienceDirect
![Absolute excess risk of basal cell carcinoma (+ 95% CI) over baseline... | Download Scientific Diagram Absolute excess risk of basal cell carcinoma (+ 95% CI) over baseline... | Download Scientific Diagram](https://www.researchgate.net/profile/Mark-Little-2/publication/338203271/figure/fig1/AS:963226976129024@1606662615457/Absolute-excess-risk-of-basal-cell-carcinoma-95-CI-over-baseline-level-defined-by_Q640.jpg)
Absolute excess risk of basal cell carcinoma (+ 95% CI) over baseline... | Download Scientific Diagram
![Resistencias al tratamiento no quirúrgico en cáncer cutáneo no melanoma. Parte I: tratamientos tópicos - ScienceDirect Resistencias al tratamiento no quirúrgico en cáncer cutáneo no melanoma. Parte I: tratamientos tópicos - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000173101630151X-gr4.jpg)
Resistencias al tratamiento no quirúrgico en cáncer cutáneo no melanoma. Parte I: tratamientos tópicos - ScienceDirect
![Resistencias al tratamiento no quirúrgico en cáncer cutáneo no melanoma. Parte I: tratamientos tópicos - ScienceDirect Resistencias al tratamiento no quirúrgico en cáncer cutáneo no melanoma. Parte I: tratamientos tópicos - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000173101630151X-gr1.jpg)
Resistencias al tratamiento no quirúrgico en cáncer cutáneo no melanoma. Parte I: tratamientos tópicos - ScienceDirect
![Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells | British Journal of Cancer Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2014.421/MediaObjects/41416_2014_Article_BFbjc2014421_Fig1_HTML.jpg)
Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells | British Journal of Cancer
![PDF) 263 . C. ESPOSITO, AL. CREMA, A.PONZETTO, G.MURTAS, G. CARLONI. Multifunctional anti-cancer nano-platforms are moving towards clinical trials.Curr Drug Metab. 2013;14(5):583-604.PMID:23687926. PDF) 263 . C. ESPOSITO, AL. CREMA, A.PONZETTO, G.MURTAS, G. CARLONI. Multifunctional anti-cancer nano-platforms are moving towards clinical trials.Curr Drug Metab. 2013;14(5):583-604.PMID:23687926.](https://www.researchgate.net/profile/Antonio-Ponzetto/publication/267324205/figure/tbl3/AS:667836607369220@1536236063090/Nanoparticles-for-cancer-treatment-in-preclinical-trials_Q320.jpg)
PDF) 263 . C. ESPOSITO, AL. CREMA, A.PONZETTO, G.MURTAS, G. CARLONI. Multifunctional anti-cancer nano-platforms are moving towards clinical trials.Curr Drug Metab. 2013;14(5):583-604.PMID:23687926.
![PDF) 263 . C. ESPOSITO, AL. CREMA, A.PONZETTO, G.MURTAS, G. CARLONI. Multifunctional anti-cancer nano-platforms are moving towards clinical trials.Curr Drug Metab. 2013;14(5):583-604.PMID:23687926. PDF) 263 . C. ESPOSITO, AL. CREMA, A.PONZETTO, G.MURTAS, G. CARLONI. Multifunctional anti-cancer nano-platforms are moving towards clinical trials.Curr Drug Metab. 2013;14(5):583-604.PMID:23687926.](https://i1.rgstatic.net/publication/267324205_263_C_ESPOSITO_AL_CREMA_APONZETTO_GMURTAS_G_CARLONI_Multifunctional_anti-cancer_nano-platforms_are_moving_towards_clinical_trialsCurr_Drug_Metab_2013145583-604PMID23687926/links/54745c860cf2778985abda5a/largepreview.png)
PDF) 263 . C. ESPOSITO, AL. CREMA, A.PONZETTO, G.MURTAS, G. CARLONI. Multifunctional anti-cancer nano-platforms are moving towards clinical trials.Curr Drug Metab. 2013;14(5):583-604.PMID:23687926.
![DOC) Multifunctional anti-cancer nano-platforms are moving to clinical trials | antonio ponzetto, Giovanni Murtas, and Annalisa Crema - Academia.edu DOC) Multifunctional anti-cancer nano-platforms are moving to clinical trials | antonio ponzetto, Giovanni Murtas, and Annalisa Crema - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/32611344/mini_magick20190414-15663-5es7r1.png?1555248441)